FDA
- Status: approved
🇺🇸 Pharmacotherapy to slow and control ventricular rate in United States
Pharmacotherapy to slow and control ventricular rate (Pharmacotherapy to slow and control ventricular rate) regulatory status in United States.
Marketing authorisation
Pharmacotherapy to slow and control ventricular rate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Pharmacotherapy to slow and control ventricular rate approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Pharmacotherapy to slow and control ventricular rate in United States?
National Institute of Cardiology, Warsaw, Poland is the originator. The local marketing authorisation holder may differ — check the official source linked above.